Ventilator Ventilator-Associated Associated Pneumonia Pneumonia ...

More documents

Recommendations

Info

Corticosteroid use on Diagnosis of ICU-acquired <strong>Pneumonia</strong>Indication, n (%)Exacerbation of respiratory diseaseNeurological disordersSeptic shockLong-term use of steroidsMultiple reasonsOthersAdministered drug, n (%)MethylprednisoloneDexamethasoneHydrocortisonePrednisolonePrevalence of long-term use, n (%)41 (33)34 (27)18 (14)12 (10)11 (9)9 (7)67 (54)34 (27)22 (18)2(2)29 (23)Cumulative dose median [interquartilerange] Length of treatment (days)6 [3-10]Total dose (mg)380 [160-805]Average daily dose (mg/day) 50 [34-142]Ranzani OT et al. Crit Care Med 2012; 40: 2552-2561
1.00.9No treatmentSurvival0.80.70.6Corticosteroid treatment0.5Log-Rank test: 4.006P value: 0.0450.00 7 14 21 28Time (days since pneumoniaNo. patients at riskCorticosteroids treatmentNo treatment125191diagnosis)1081759115478135Ranzani OT et al. Crit Care Med 2012; 40: 2552-2561
Page 4: VAP Rates in the USA10.03000Mean VA
Page 8 and 9: Diagnostic Accuracy of CPIS: A Meta
Page 10 and 11: First AuthorYearSensitivity95% CITe
Page 12 and 13: Diagnosing VAP in Critically Ill Pa
Page 14: Prognostic Value in VAP1.00.8Sensit
Page 17 and 18: Quantitative vs. qualitative cultur
Page 19 and 20: Common Causes of VAP - Bronchoscopi
Page 21 and 22: Risk Factors for MDR Pathogens Anti
Page 23 and 24: 10093.3908076.5Mortality (%)7060504
Page 25 and 26: 1.00.8Mild riskSurvival0.60.4High r
Page 27 and 28: The VAP PIRO ScorePIROcomorbidities
Page 29 and 30: Short course vs. Prolonged Antibiot
Page 31: Screened patients after daily round
Page 35 and 36: Pharmacologic-based Strategies for
Page 37 and 38: 186 citations14 potentiallyeligible
Page 39: Specific Quality improvement interv

Ventilator Ventilator-Associated Associated Pneumonia Pneumonia ...

Create successful ePaper yourself

Delete template?

Save as template?